TherapeuticsMD Announces Multiple Presentations Related to Yuvvexy™ (TX-004HR) at Two Upcoming Medical Conferences
IMTC Expands Charter of SDN Activity Group to Meet Broader Market Demands
Global Nanopatterning Strategic Business Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: AMO, EV Group, Nanonex - Research and Markets
Dr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market Hyderabad, India, August 29, 2016
Alvogen Launches First Generic Equivalent of CopaxoneTM in Europe
IMS Health is on the right track for growth.
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.
Any statements of opinion constitute only current opinions of The Boston Company Asset Management, LLC (TBCAM), which are subject to change and which TBCAM does not undertake to update. Due to, among other things, the volatile nature of the markets and the investment areas discussed herein, they ...